Media

Publications

  1. Rappaport, N., Twik, M., Nativ, N., Stelzer, G., Bahir, I., Stein, T. I., Safran, M. and Lancet, D. MalaCards: A Comprehensive Automatically-Mined Database of Human DiseasesCurr. Protoc. Bioinform. 47:1.24:1.24.11.24.19. (Sept 2014).
  2. Lancet D, Stelzer G, Golan Y, and Rinon A. Gene Trends: On Muscle, Fat, and Brain Genetic Engineering & Biotechnology News, Dec 16, 2013.
  3. Lancet D, Golan Y, Leshansky L, and Stelzer G. Gene Trends: Eye-Openers for Unusual Gene Variations Genetic Engineering & Biotechnology News, Oct 24, 2013.
  4. Lancet D, Golan Y, and Stelzer G. Gene Trends: Which Ones Should You Be Studying Now? Genetic Engineering & Biotechnology News, Oct 3, 2013.
  5. Olender T, Safran M, Edgar R, Stelzer G, Nativ N, Rosen N, Shtrichman R, Mazor Y, West M D, Keydar I, Rappaport N, Belinky F, Warshawsky D, and Lancet D.An Overview of Synergistic Data Tools for Biological Scrutiny Israel Journal of Chemistry, Volume 53, Issue 3-4, pages 185–198, April 2013.
  6. Rappaport N, Nativ N, Stelzer G, Twik M, Guan-Golan Y, Iny Stein T, Bahir I, Belinky F, Morrey CP, Safran M and Lancet D. MalaCards: an integrated compendium for diseases and their annotationDatabase 2013; doi: 10.1093/database/bat018.
  7. Belinky F, Bahir I, Stelzer G, Zimmerman S, Rosen N, Nativ N, Dalah I, Iny Stein T, Rappaport N, Mituyama M, Safran M and Lancet D. Non-redundant compendium of human ncRNA genes in GeneCardsBioinformatics 29, 2: 255-61 (2013).
  8. Safran M, Nativ N, Golan Y, Dalah I, Iny Stein T, Stelzer G, and Lancet D. MalaCards – the integrated Human Malady CompendiumISMB 2012.
  9. Stelzer G, Dalah I, Iny Stein T, Satanower Y, Rosen N, Nativ N, Oz-Levi D, Olender T, Belinky F, Bahir I, Krug H, Perco P, Mayer B, Kolker E, Safran M and Lancet, D. In-silico Human Genomics with GeneCardsHuman Genomics, 2011 Oct;5(6):709-17.
  10. Harel A, Dalah I, Pietrokovski M, Safran M and Lancet D. Omics Data Management and Annotation, Chapter 3 Bioinformatics for Omics Data: Methods and Protocols Series: Methods in Molecular Biology, Vol. 719, ISBN: 978-1-61779-026-3, Mayer, Bernd (Ed.), Humana Press, March, 2011
  11. Safran M, Dalah I, Alexander J, Rosen N, Iny Stein T, Shmoish M, Nativ N, Bahir I, Doniger T, Krug H, Sirota-Madi A, Olender T, Golan Y, Stelzer G, Harel A and Lancet D. GeneCards Version 3: the human gene integrator Database 2010; doi: 10.1093/database/baq020
  12. Stelzer G, Inger A, Olender T, Iny Stein T, Dalah I, Harel A, Safran M and Lancet D. GeneDecks: paralog hunting and gene-set distillation with GeneCards annotation OMICS, 2009, 13(6)
  13. Harel A, Inger A, Stelzer G, Strichman-Almashanu L, Dalah I, Safran M and Lancet D. GIFtS: annotation landscape analysis with GeneCards BMC Bioinformatics 2009, 10:348
  14. Stelzer G, Harel A, Inger A, Olender T, Dalah I, Shmoish M, Ron S, Safran M and Lancet D. GeneDecks: GeneCards-based paralog hunting and gene set distillation. CSB2008 Aug, 2008
  15. Lancet D, Safran M, Olender T, Dalah I, Iny-Stein T, Inger A, Harel A and Stelzer G. GeneCards tools for combinatorial annotation and dissemination of human genome information GIACS Conference on Data in Complex Systems April, 2008
  16. Stelzer G, Harel A, Dalah A, Rosen N, Shmoish M, Iny Stein T, Sirota A, Madi A, Safran M and Lancet D. GeneCards: One stop site for human gene researchFISEB (ILANIT), Jan, 2008
  17. Ferrari F, Bortoluzzi S, Coppe A, Sirota A, Safran M, Shmoish M, Ferrari S, Lancet D, Danieli G A, and Bicciato S. Novel definition files for human GeneChips based on GeneAnnot. BMC Bioinformatics 2007, 8:446 (15 NOV 2007).
  18. Safran M, Dalah I, Ron S, Shmoish M, Iny-Stein T, Rosen N, Madi A, Sirota A, Stelzer G and Lancet D. GeneDecks annotation combinatorics and unification for human genes. ISMB ECCB 2007
  19. Ron S, Strichman-Almashanu L, Shmoish M, Greenshpan O, Sirota A, Madi A, Iny-Stein T, Rosen N, Dalah I, Shmueli O, Safran M, Aumann Y, and Lancet D.GeneDecks: Gene-Set Analyses of GeneCards Annotations. ECCB 2006.
  20. Lancet D, Ron S, Shmoish M, Madi A, Sirota A, Noy K, Rosen N, Greenshpan O, Shmueli O, Safran M, Aumann Y, and Strichman-Almashanu L. GeneDecks: A Systems Biology Facilitator with Combinatorial GeneCards Display. Transcriptome 2005.
  21. Ron S, Strichman-Almashanu L, Shmoish M, Madi A, Sirota A, Noy K, Rosen N, Shmueli O, Safran M, and Lancet D. GeneDecks: A Systems Biology Facilitator With Combinatorial GeneCards Outlook. Poster and abstract at ISMB 2005.
  22. Shklar M, Strichman-Almashanu L, Shmueli O, Shmoish M, Safran M, and Lancet D. GeneTide--Terra Incognita Discovery Endeavor: a new transcriptome focused member of the GeneCards/GeneNote suite of databases. Nucleic Acids Res. 33: D556 - D561 (2005).
  23. Yanai I, Benjamin H, Shmoish M, Chalifa-Caspi V, Shklar M, Ophir R, Bar-Even A, Horn-Saban S, Safran M, Domany E, Lancet D, Shmueli O. Genome-wide midrange transcription profiles reveal expression level relationships in human tissue specification. Bioinformatics 21, 5: 650-659 (2005).
  24. Shklar, M., Shmueli, O., Strichman-Almashanu, L., Shmoish, M., Iny-Stein, T., Safran, M. and Lancet, D. TIDE--Terra Incognita Discovery Endeavor: Comprehensive EST assignment to GeneCards genes. Short paper and talk at ISMB/ECCB 2004.
  25. Chalifa-Caspi, V., Yanai, I., Ophir, R., Rosen, N., Shmoish, M., Benjamin-Rodrig, H., Iny Stein, T., Shmueli, O., Safran, M. and Lancet, D. GeneAnnot: comprehensive two-way linking between oligonucleotide array probesets and GeneCards genes. Bioinformatics 20, 9: 1457-1458 (2004).
  26. Chalifa-Caspi, V., Shmueli, O., Benjamin-Rodrig, H., Rosen, N., Shmoish, M., Yanai, I., Ophir, R., Kats, P., Safran, M. and Lancet, D. GeneAnnot: Interfacing GeneCards with high throughput gene expression compendia. Briefings in Bioinformatics 4, 4: 349-360 (2003).
  27. Safran, M., Chalifa-Caspi, V., Shmueli, O., Rosen, N., Benjamin-Rodrig, H., Ophir, R., Yanai, I., Shmoish, M., and Lancet, D. The GeneCards Family of Databases: GeneCards, GeneLoc, GeneNote and GeneAnnot. Proceedings of the IEEE Computer Science Bioinformatics Conference CSB2003, (2003) (Poster Abstract at CSB2003).
  28. Shmueli, O., Horn-Saban, S., Chalifa-Caspi, V., Shmoish, M., Ophir, R., Benjamin-Rodrig, H., Safran, M., Domany, E., and Lancet, D. GeneNote: whole genome expression profiles in normal human tissues. Comptes Rendus Biologies: 326, 10-11:1067-1072 (2003).
  29. Chalifa-Caspi, V., Yanai, I., Ophir, R., Shmoish,M., Benjamin-Rodrig, H., Rosen, N., Kats, P., Safran, M., Shmueli, O., and Lancet, D. GeneAnnot: Annotation of high-density oligunocleotide arrays and their linking with GeneCards. Poster Abstract at ISMB 2003
  30. Rosen, N., Chalifa-Caspi, V., Shmueli, O., Adato, A., Lapidot, M., Stampnitzky, J., Safran, M., and Lancet, D. GeneLoc: Exon-based integration of human genome maps. Bioinformatics: 19,S1: 222-224 (2003).
  31. Safran, M., Chalifa-Caspi, V., Shmueli, O., Olender, T., Lapidot, M., Rosen, N., Shmoish, M., Peter, Y., Glusman, G., Feldmesser, E., Adato, A., Peter, I., Khen, M., Atarot, T., Groner, Y., and Lancet, D. Human Gene-Centric Databases at the Weizmann Institute of Science: GeneCards, UDB, CroW 21 and HORDE .Nucleic Acids Research 31,1:142-146 (2003).
  32. Safran, M., Solomon, I., Shmueli, O., Lapidot, M., Shen-Orr, S., Adato, A., Ben-Dor, U., Esterman, N., Rosen, N., Peter, I., Olender, T., Chalifa-Caspi, V., and Lancet, D. GeneCards 2002: towards a complete, object-oriented, human gene compendiumBioinformatics: 18,11: 1542-1543 (2002).
  33. Safran, M., Solomon, I., Shmueli, O., Lapidot, M., Shen-Orr, S., Adato, A., Ben-Dor, U., Esterman, N., Rosen, N., Peter, I., Olender, T., Chalifa-Caspi, V., and Lancet, D. GeneCards 2002: An Evolving Human Gene Compendium. Proceedings of the IEEE Computer Science Bioinformatics Conference CSB2002, p. 339 (2002).
  34. Rebhan, M., Chalifa-Caspi, V., Prilusky, J., and Lancet, D. GeneCards: A novel functional genomics compendium with automated data mining and query reformulation support. Bioinformatics: 14: 656-664 (1998).
  35. Rebhan, M., Prilusky, J. Rapid access to biomedical knowledge with GeneCards and HotMolecBase: Implications for the electrophoretic analysis of large sets of gene products. Electrophoresis, special issue on 'Biomedicine and Biocomputing', vol. 18: 2774-80 (1997).
  36. Rebhan, M., Chalifa-Caspi, V., Prilusky, J., Lancet, D. GeneCards: integrating information about genes, proteins and diseases. Trends in Genetics 13: 163 (1997).


  1. Rappaport, N., Twik, M., Nativ, N., Stelzer, G., Bahir, I., Stein, T. I., Safran, M. and Lancet, D. 
    MalaCards: A Comprehensive Automatically-Mined Database of Human DiseasesDatabase, Sep 8, 2014.
  2. Rappaport, N, Nativ, N, Stelzer, G, Twik, M, Guan-Golan, Y, Iny Stein, T, Bahir, I, Belinky, F, Morrey, P, Safran, M, and Lancet, D. 
    MalaCards: an integrated compendium for diseases and their annotationDatabase, Apr 16, 2013.
  3. Safran, M, Nativ, N, Golan, Y, Dalah, I, Iny Stein, T, Stelzer, G, and Lancet, D. 
    MalaCards - the integrated Human Malady CompendiumISMB 2012, Mar 6, 2012.


  1. Buzhor E, Leshansky L, Blumenthal J, Barash H, Warshawsky D, Mazor Y, and Shtrichman R.
    Cell-based therapy approaches: the hope for incurable diseases. Future Medicine, Sep 5, 2014.
  2. Edgar, R., Mazor, Y., Rinon, A., Blumenthal, J., Golan, Y., Buzhor, E., Livnat, I., Ben-Ari, S., Lieder, I., Shitrit, I., Gilboa, Y., Ben-Yehudah, A., Edri, O., Shraga, N., Bogoch, Y., Leshansky, L., Aharoni, S., West, M., Warshawsky, D., Shtrichman, R. 

    LifeMap Discovery™: The Embryonic Development, Stem Cells, and Regenerative Medicine Research Portal. PlosOne, Jul 17, 2013.

Press

20 January 2016

LifeMap Sciences, a Subsidiary of BioTime, Announces the Launch of TGex, the Knowledge-Driven NGS Analysis Platform, Powered by the GeneCards Suite

LifeMap Sciences, Inc. (“LifeMap”), a life sciences technology company and subsidiary of BioTime, Inc., announced today the market launch of TGex™ (Translational Genomics Expert), an integrated next-generation genomic sequencing (NGS) analysis platform. TGex leverages the GeneCards Suite Knowledgebase to rapidly identify genetic variants that may impact disease management and health outcomes, eliminating a traditional research bottleneck and enabling streamlined, efficient exploration and utilization of sequencing data for research, as well as exploring diagnostic and therapeutic utility in the rapidly growing, global NGS market. TGex™ was developed in partnership with Toldot Genetics, LTD (Toldot), a subsidiary of BATM Advanced Communications, Ltd.

Read more

02 December 2015

LifeMap Sciences Partners with MedGenome to Enrich NGS Analysis Reporting with Oncology Data

LifeMap Sciences, Inc. (“LifeMap”), a life sciences technology company and a subsidiary of BioTime, Inc., and MedGenome, Inc. (“MedGenome”), a genomics-based diagnostics and research company, announced today a global collaboration agreement. The agreement will strengthen LifeMap’s next generation sequencing (NGS) analysis solutions in the oncology field by incorporating data from MedGenome’s OncoMD database for use by LifeMap clients. The Oncology NGS market is a significant growth driver within the multi-billion dollar global NGS market.

Read more

04 November 2015

LifeMap Sciences, a Subsidiary of BioTime, and Lab7 Systems Announce Partnership and Launch of Integrated NGS Analysis Solution

LifeMap Sciences, Inc. (“LifeMap”), a subsidiary of BioTime, Inc., and Lab7 Systems, Inc., announced today a partnership and launch of an integrated solution in the next-generation genomic sequencing (NGS) field, a multi-billion dollar, rapidly growing global market. LifeMap’s VarElect, The NGS Phenotyper, is now integrated into the Lab7 Enterprise Science Platform’s (ESP™) DNA sequence analysis, outputs and reports, enabling Lab7 ESP users to purchase access for enhanced variant gene prioritization and review of biological evidence linking variant genes to diseases and phenotypes of interest. Lab7 ESP, a solution for sample, data, and analysis management for NGS labs, supports life-science analytics at hospitals and medical research centers and organizations.

Read more

08 October 2015

LifeMap Sciences’ NGS Analysis and Interpretation Tools VarElect and GeneAnalytics Licensed by SciLifeLab

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today that its next generation sequencing (“NGS”) analysis and interpretation tools, VarElect (http://varelect.genecards.org), the NGS phenotyper, and GeneAnalytics™ (http://geneanalytics.genecards.org/), a novel gene set analysis tool, has been licensed by SciLifeLab (www.scilifelab.se). SciLifeLab is a Sweden-based leading provider of molecular biosciences services to leading biomedical research institutions and companies. The LifeMap NGS tools will be utilized by SciLifeLab bioinformatics and biologists to enhance the bioinformatics analysis services that it provides across Sweden.

Read more

15 July 2015

LifeMap Sciences Announces the Next Generation of GeneCards® - Version 4.0

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneCards® Version 4.0 with a new technology platform and redesigned user interface. The new release is available now at www.genecards.org. GeneCards is a database that provides comprehensive information on all known human genes, and is available via the cloud and onsite installation. GeneCards 4.0 is a major empowering technology for LifeMap’s next generation sequencing (“NGS”) analysis and interpretation platform which was launched in 2015.

Read more

25 February 2015

LifeMap Sciences Partners with Toldot Genetics to Support Next Generation Sequencing Variant Analysis Commercialization

LifeMap Sciences, Inc. (LifeMap), a subsidiary of BioTime, Inc., announced today a commercial partnership agreement with Toldot Genetics, LTD (Toldot), a subsidiary of BATM Advanced Communications, Ltd. LifeMap’s GeneCards Suite, comprised of the company’s integrated biomedical knowledgebase and premium analysis tools, will optimize Toldot’s next generation sequencing (NGS) data analysis capabilities by powering its algorithm-based tools for assigning genetic variations derived from whole genome and exome sequencing, to clinical conditions in order to improve biomedical research. LifeMap will also promote Toldot’s products and offer them to its large user base of life scientists in academia, research hospitals, and biopharma.

Read more

19 February 2015

LifeMap Sciences Launches GeneAnalytics 1.1 With Improved Next Generation Sequencing Data Analysis Features

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneAnalytics™ v1.1, a powerful and easy-to-use gene set analysis tool that rapidly contextualizes RNAseq and microarray-derived gene expression patterns and function signatures.

Read more

04 February 2015

LifeMap Sciences Announces Partnership with Advaita and Commercial Availability of Advaita’s iPathwayGuide in GeneCards®

Advanced pathway analysis tool offered to LifeMap’s GeneCards’ users in more than 3,000 institutions in academia, research hospitals, and leading biopharma companies.

Read more

20 January 2015

LifeMap Releases NGS Phenotyper

BioIT World discusses the release of VarElect, the Next Generation Sequencing Phenotyper.

Read more

15 January 2015

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of VarElect, a powerful, yet easy-to-use application for prioritizing gene variants resulting from next generation sequencing (“NGS”) experiments. VarElect rapidly prioritizes gene variants according to their potential association to a disease or phenotype of interest, and can aid in identifying the roles of genes and their variants in biological processes, health, and disease.

Read more

11 December 2014

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of MalaCards Version 1.07 With Additional Types of Clinical Significance From ClinVar and New Phenotypes From HPO

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of MalaCards, Version 1.07. The new release is available at www.malacards.org.

Read more

06 October 2014

LifeMap Sciences Announces Release and Commercial Availability of GeneAnalytics™ 1.0, a Powerful Gene Set Analysis Tool powered by GeneCards®, LifeMap Discovery® and MalaCards

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the commercial release of GeneAnalytics 1.0 atwww.geneanalytics.com. GeneAnalytics™ is a powerful, yet easy to use, gene set analysis tool designed to help life scientists and biomedical researchers identify expression signatures and functionality of their experimental gene sets, and define their roles in various biological processes and in health and disease.

Read more

06 October 2014

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of MalaCards Version 1.06 with greatly improved gene-disease associations

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the recent release of MalaCards, Version 1.06. The new release is available at http://www.malacards.org/, and features greatly improved gene-disease associations. MalaCards is a database of human diseases and their annotations that is modeled on the architecture and richness of the popular GeneCards® database of human genes (http://www.genecards.org/). The database consolidates disease data from 66 sources and in this version contains 19,663 disease entries, 11,808 of which include associated genes.

Read more

01 October 2014

LifeMap Solutions Adds Chief Technology Officer to Leadership Team

BioTime, Inc. (NYSE MKT:BTX) and its subsidiary LifeMap Solutions, Inc., a medical technology company, today announced significant additions to the LifeMap Solutions management team. LifeMap Solutions is partnering with the Icahn Institute at Mount Sinai to create innovative mobile health (mHealth) products and services backed by big data. Today the company announced the appointment of Rafhael Cedeno as Chief Technology Officer and Head of Product, as well as the addition of Joel Dudley, PhD, Rong Chen, PhD, and Elissa Levin from the Icahn Institute as members of the LifeMap Solutions science team.

Read more

10 July 2014

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.12 and the Introduction of GeneCards Plus™

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of GeneCards® Version 3.12. The new release is available at www.genecards.org. GeneCards® is an online database that provides comprehensive information on all known human genes. The new release features the launch of LifeMap Science’s Premium Services platform, which offers our strong user base access to GeneCards Plus’ powerful tools and advanced functionality integrated with the LifeMap Integrated Knowledgebase, which includes GeneCards®, MalaCards and LifeMap Discovery®.

Read more

07 May 2014

LifeMap Solutions Emerges To Develop Bid Data-Powered Mobile Health Products

LifeMap Solutions Partners with Icahn School of Medicine at Mount Sinai; Leadership Team Includes Deep Biotech and Silicon Valley Experience. LifeMap Solutions, Inc., (http://lifemap-solutions.com) a medical technology startup focused on creating innovative mobile health (mHealth) products and services powered by big data, today announced an initial $5 million seed round led by parent company LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., with additional participation via in-kind support from its development partner, the Icahn School of Medicine at Mount Sinai.

Read more

13 March 2014

LifeMap Sciences Announces Release of LifeMap Discovery® Version 1.6 with Tissue-Specific, Fully Annotated Summaries of Gene Expression

LifeMap Sciences, Inc. announced today the release of LifeMap Discovery® version 1.6 (http://discovery.lifemapsc.com). LifeMap Discovery® is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology, disease mechanisms and etiology.

Read more

10 March 2014

LifeMap Sciences Announces Release of MalaCards Version 1.05 with New Categorization

LifeMap Sciences, Inc. announced today the release of MalaCards, Version 1.05. The new release is available at www.malacards.org. MalaCards is a database of human diseases and their annotations that is modeled on the architecture and richness of the popular GeneCards ® database of human genes (http://genecards.org ). The database consolidates disease data from 61 sources and in this version contains 19,392 disease entries, 11,915 of which include associated genes. LifeMap Sciences holds the exclusive worldwide license to market MalaCards from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.

Read more

17 January 2014

BioTime’s Subsidiary LifeMap Sciences Announces Release of LifeMap Discovery™ Version 1.5 with GeneAnalytics™, a Powerful Gene Expression Analysis Tool

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery™ version 1.5. LifeMap Discovery™ is a state-of-the-art roadmap of embryonic development and stem cell biology. The product integrates embryonic development and stem cell biology, molecular, cellular, anatomical, and disease-related information, and provides data-mining capabilities and bioinformatics applications. As such, it is a unique and powerful tool for research and discovery in multiple disciplines, including stem cell biology, developmental biology, disease mechanisms and etiology.

Read more

20 December 2013

BioTime Reports Isolation of Novel Brain-Associated Cells From Human Embryonic Stem Cells

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine reported today the publication of a peer-reviewed scientific paper on the successful generation of human cells with markers of particular cell types in the human brain, potentially useful in the treatment of neurological diseases such as Alzheimer’s disease. The paper published online (ahead of print) in the journal Regenerative Medicine, characterizes the cells generated from human embryonic stem cells using BioTime’s proprietary PureStem&trade technology. The study reports that the new cell lines show the potential to become cartilage and bone as well as brain-associated cells such as membranes surrounding the brain called meninges and choroid plexus (the structure in the brain that creates cerebrospinal fluid). These novel expandable and highly purified progenitors have properties that may have a wide array of future applications in the practice of orthopedics and neurology.

Read more

06 December 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.11

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.11. The new release is available at http://genecards.org. GeneCards ® is a comprehensive online database that provides comprehensive information on all human genes. It is accessed by professionals in many institutions including academia, research hospitals, patent offices, and leading biotech and pharma companies. LifeMap Sciences holds the exclusive worldwide license to market GeneCards® from Yeda Research and Development Company Ltd., the commercial arm of the Weizmann Institute of Science.

Read more

04 December 2013

BioTime’s CEO, Dr. Michael West to Moderate Session on Mapping the Cellular Basis of Life at the 2013 World Stem Cell Summit

BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, announced that BioTime’s CEO, Dr. Michael West will lead a session titled “From Mapping the Genome to Mapping the Embryome: The Urgent Need for an International Initiative” today at the 2013 World Stem Cell Summit in San Diego, California. The session will include world leaders in stem cell biology discussing how major advances in stem cell science and human health could be achieved by databasing the cellular components of the human body. In addition to Dr. West, Dr. Ronit Shtrichman, Technical Vice President of BioTime’s Israeli subsidiary LifeMap Sciences Ltd., will give a presentation titled “LifeMap Discovery ™: An online database, integrating molecular and cellular information on embryonic development to improve stem cell research.

Read more

06 August 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of MalaCards Version 1.04

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc., announced today the release of MalaCards, Version 1.04. The new release is available at http://www.malacards.org.

Read more

26 July 2013

LifeMap Sciences Announces Release of LifeMap Discovery™ Version 1.2 with Extensive Stem Cell Therapy Data

LifeMap Sciences, Inc. announced today the release of LifeMap Discovery™ version 1.2 (discovery.lifemapsc.com) which includes significant enhancements to stem cell therapy data, consolidation of related data under the organ card, additional high-throughput sources and coverage of the dermis.

Read more

18 July 2013

Publication of Research Report Describing LifeMap Discovery™

The LifeMap Discovery product has been documented in a published paper authored by LifeMap Sciences’ research and development team. The publication titled “LifeMap Discovery™: The embryonic development, stem cells, and regenerative medicine research portal” is available via the open access peer-reviewed journal PLOS ONE and can be viewed via the link http://dx.plos.org/10.1371/journal.pone.0066629. The publication describes the scientific and technological foundations of LifeMap Discovery, the first road map of cellular embryonic development.

Read more

07 May 2013

BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™ Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research

ALAMEDA, Calif.--(BUSINESS WIRE)--May. 7, 2013-- BioTime, Inc. (NYSE MKT: BTX) and subsidiary, LifeMap Sciences, today announced the release of the enhanced LifeMap BioReagents™ portal (http://bioreagents.lifemapsc.com/) featuring an improved user interface, product descriptions, and customer support options, as well as the addition of new PureStem™ progenitor cells to the site

Read more

30 April 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.10

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.10. The new release is available at www.genecards.org.

Read more

23 April 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Partnership with Appistry

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today a collaborative partnership and value-added reseller agreement with Appistry, Inc., which provides big-data computing that supports life-science and medical analytics at hospitals and medical research centers and organizations.

Read more

18 April 2013

LifeMap Sciences Announces Publication of Research Report Describing the MalaCards Database of Human Diseases

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that its MalaCards database has been recognized in a published paper by the Weizmann Institute of Science research group under the supervision of Prof. Doron Lancet from the Department of Molecular Genetics, in collaboration with LifeMap Sciences.

Read more

18 April 2013

LifeMap Sciences Announces Publication of Research Report Describing the MalaCards Database of Human Diseases

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that its MalaCards database has been recognized in a published paper by the Weizmann Institute of Science research group under the supervision of Prof. Doron Lancet from the Department of Molecular Genetics, in collaboration with LifeMap Sciences.

Read more

10 April 2013

LifeMap Sciences Adds Products Through Partnership with ProSpec-Tany TechnoGene

- BioTime Subsidiary offers 100 select recombinant proteins in its BioReagents Portal -
ALAMEDA, Calif.--(BUSINESS WIRE)--Apr. 10, 2013-- LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that it is now offering 100 selected ProSpec-Tany TechnoGene (ProSpec) manufactured recombinant proteins related to stem cell research in its recently launched LifeMap BioReagents™ portal.

Read more

25 March 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of LifeMap Discovery™ Version 1.1 with Enhanced Therapeutic Discovery and Commercial Utility

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of LifeMap Discovery™ version 1.1. LifeMap Discovery™ is a key component in LifeMap's integrated database suite, a discovery platform for biomedical and stem cell research, which also includes GeneCards®, the leading human gene database, and MalaCards, the human disease database.

Read more

04 March 2013

BioTime and Subsidiary LifeMap Sciences Announce Data Mining Collaboration

BioTime, Inc. (NYSE MKT: BTX) and its bioinformatics subsidiary LifeMap Sciences, Inc. (“LifeMap”) today announced that they have entered into a definitive collaboration agreement to utilize LifeMap’s computer-based tools to extract information relating to novel potential commercial products.

Read more

11 February 2013

LifeMap Sciences, a Subsidiary of BioTime, Reports Its Databases Currently Utilized by an Estimated Two Million Unique Visitors Annually according to Google Analytics

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT:BTX), announced today that according to Google Analytics, the Company’s databases have attracted over two million unique visitors in the previous 12 months.

Read more

30 January 2013

LifeMap Sciences, a Subsidiary of BioTime, Announces Publication of Research Report Describing Non-Redundant Compendium of Human Non-Coding RNA Authored by GeneCards Scientists

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the publication of a paper authored by a research group under the supervision of Prof. Doron Lancet from the Department of Molecular Genetics at the Weizmann Institute of Science describing the analysis and display of a non-redundant compendium of human non-coding RNA genes, which was made available as part of GeneCards® Version 3.09.

Read more

09 January 2013

LifeMap Sciences, a Subsidiary of BioTime, Inc., Announces the Release of MalaCards Version 1.02

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of MalaCards version 1.02 on January 7. The new release is available at www.malacards.org.

Read more

18 December 2012

BioTime Reports Isolation of Seven Diverse Cartilage and Bone Cell Types From Human Embryonic Stem Cells

BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, and its subsidiaries OrthoCyte Corporation and LifeMap Sciences reported today a means of manufacturing seven distinct types of cartilage, bone, and tendon cells from human embryonic stem cells.

Read more

27 November 2012

LifeMap Sciences, a Subsidiary of BioTime, Inc., Launches LifeMap Discovery™: A Database of Human Cellular Life for the Field of Regenerative Medicine

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the launch of LifeMap Discovery™ (discovery.lifemapsc.com), a state-of-the-art roadmap of embryonic development and stem cell biology.

Read more

20 November 2012

LifeMap Sciences, a Subsidiary of BioTime, Signs Definitive Distribution Agreement with ProSpec-Tany TechnoGene

LifeMap Sciences, Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that it has signed a definitive distribution agreement with ProSpec-Tany TechnoGene Ltd. (ProSpec).

Read more

19 November 2012

LifeMap Sciences, a Subsidiary of BioTime, Announces Release of GeneCards® Version 3.09

LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today the release of GeneCards®, Version 3.09, on November 18, 2012. The new release is available at www.genecards.org

Read more

14 November 2012

BioTime and Subsidiary LifeMap Sciences Announce the Launch of LifeMap BioReagents™ Portal

BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences have announced the launch of LifeMap BioReagents. (bioreagents.lifemapsc.com), a new portal offering researchers access to BioTime's research product lines

Read more

23 October 2012

BioTime's Subsidiary LifeMap Sciences, Inc. Announces the Launch of MalaCards - A Database of Human Diseases

BioTime, Inc. (NYSE MKT: BTX) and LifeMap Sciences, Inc. announce the launch of MalaCards, a new database of human diseases that is based on their leading GeneCards® platform.

Read more

19 October 2012

LifeMap Sciences, Inc. Announces Addition to Board of Directors and Provides Update on Product Portfolio Development

BioTime, Inc. (NYSE MKT: BTX) and its subsidiary, LifeMap Sciences, Inc., today announced the appointment of Louis E. Silverman to LifeMap Sciences' board of directors.

Read more

26 July 2012

BioTime Subsidiary LifeMap Sciences, Inc. Announces Financing of Up to $3 Million from Share Exchange Agreement

BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences, Inc. ("LifeMap") today announced that LifeMap entered into a Share Exchange and Contribution Agreement with Alfred D. Kingsley and a company that he controls, Greenway Partners, L.P.

Read more

23 May 2012

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Release of GeneCards® Version 3.08

XenneX, a Division of LifeMap Sciences, Inc. and BioTime, Inc. (NYSE Amex:BTX), announced today the release of GeneCards®, Version 3.08, on May 20, 2012. The new release is available at www.genecards.org.

Read more

22 May 2012

BioTime and Subsidiary LifeMap Sciences, Inc. Announce Agreement to Market MalaCards - A Database of Human Diseases.

BioTime, Inc. (NYSE MKT: BTX) today announced that its subsidiary LifeMap Sciences, Inc. has entered into a license agreement with Yeda Research and Development Company Ltd, the technology transfer arm of the Weizmann Institute of Science, to market a new database called MalaCards.

Read more

21 May 2012

BioTime Completes Merger of Xennex, Inc. into LifeMap Sciences, Inc.

BioTime, Inc. (NYSE MKT: BTX) and its subsidiary LifeMap Sciences, Inc. today announced that they have completed the acquisition of Xennex, Inc...

Read more

20 April 2012

BioTime and Subsidiary LifeMap Sciences Announce Agreement to Acquire XenneX, Inc.

BioTime, Inc. (NYSE Amex:BTX) and its wholly owned subsidiary LifeMap Sciences today announced that they have signed a definitive agreement to acquire XenneX.

Read more

21 December 2011

BioTime Signs Agreement with USCN Life Science to Source Antibody-Based Products

BioTime, Inc. (NYSE Amex: BTX) today announced agreements with USCN Life Science, Inc. (USCN) of Wuhan, China, granting BioTime an option to license USCN's antibody-producing cell lines.

Read more

14 November 2011

BioTime Cell Information now available in GeneCards

BioTime, Inc. (NYSE Amex: BTX) and XenneX, Inc. today announced the inclusion of cell identification data in GeneCards® 3.07 available at www.genecards.org.2011-11-14

Read more

14 November 2011

GeneCards Version 3.07 Released

Xennex Inc. announced today the release of GeneCards®, Version 3.07, available at www.genecards.org.

Read more

05 April 2011

BioTime and XenneX Form LifeMap Sciences, Inc. to Create Roadmap for Regenerative Medicine

BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of stem cells and regenerative medicine, today announced it has formed LifeMap Sciences, Inc., in collaboration with XenneX, Inc.

Read more

02 March 2010

GeneCards Version 3.0 Released

Xennex Inc. announced today the release of GeneCards®, Version 3.0, available at www.genecards.org.

Read more

13 May 2009

GeneCards Version 3.0 Beta Released

Xennex Inc. announced today a major leap for GeneCards®, with the release of Version 3.0 beta.

Read more

20 April 2009

Xennex Inc. Providing Satoris Inc. with Latest GeneCards Tools

Xennex Inc. Providing Satoris Inc. with Latest GeneCards® Tools for Characterization of Protein Biomarkers Associated With Neurological Conditions.

Read more

22 September 2008

GeneCards Links to Tocris Research Reagents

The world leading online database of genes directly links to Tocris.

Read more

05 May 2008

Japan Patent Office Licenses GeneCards from Xennex, Inc.

Japan Patent Office Licenses GeneCards® from Xennex, Inc. Xennex, Inc. Partners with Bioscene in Japan - Expands Presence in Japan.

Read more

25 September 2005

Israeli-US initiative provides one-stop shop for gene exploration

A US-Israeli start-up is now offering pharmaceutical and biotechnology companies an innovative data mining tool that can help speed up the process of gene research enabling them to bring new life saving drugs and treatments to market quicker.

Read more

05 July 2005

Applied Biosystems' TaqMan Genomic Assays to Be Included in GeneCards

Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and Xennex, Inc., the exclusive provider of commercial licenses for the GeneCards® database of human genes, today announced an agreement whereby Applied Biosystems TaqMan(R) Genomic Assays will be accessible via GeneCards. Under the terms of agreement, Applied Biosystems will provide GeneCards customers direct access to its entire collection of nearly three million genomic assays.

Read more

12 May 2005

Improving the IP Search

The issues of what constitutes a new, patentable invention and what is protected by an issued patent are continuously being redefined and tested in the marketplace and in the courts. Effective resources to draft, prosecute, and examine patent applications, such as sophisticated data sources, will benefit all sides involved in the biotech patents arena.

Read more

28 March 2005

European Patent Office Licenses GeneCards from Xennex, Inc.

Xennex Inc. announced today that the European Patent Office (EPO) has licensed its GeneCards® product. GeneCards® will be utilized to assist in the review and approval of patent applications in the life sciences area.

Read more

09 February 2005

LION bioscience and Xennex Announce Partnership

LION bioscience and Xennex Inc. today announced that they will deliver an integrated solution to the Life Science Market. Under the agreement, the two companies will develop wrappers for the human genes compendium GeneCards® enabling LION's SRS users to view GeneCards® data within SRS.

Read more